SAFETY ALERT: FDA Warns of Counterfeit Avastin (Bevacizumab), Issues Letters to 19 Medical Practices

Share this content:

The U.S. Food and Drug Administration is warning healthcare professionals and patients that a counterfeit version of Avastin (bevacizumab) 400mg/16mL was purchased and may have been used by 19 medical practices — 16 in California , 1 in Illinois, and 2 in Texas.

“The counterfeit version is labeled as Avastin, manufactured by Roche, and does not contain the medicine's active ingredient, bevacizumab, which my have resulted in patients not receiving needed therapy,” according to the FDA. In addition, the counterfeit product packaging does not resemble authentic Avastin.

Roche conducted laboratory tests that confirmed the counterfeit version of Avastin. Packages or vials may be counterfeit if they:

  • are labeled with Roche as the manufacturer
  • display batch numbers that start with B6010, B6011 or B86017

The medical practices purchased unapproved cancer medicines from Quality Specialty Products (QSP), a foreign supplier that may also be known as Montana Health Care Solutions. Volunteer Distribution in Gainesboro, Tennessee is a distributor of QSP's products. The FDA recommends that medical practices that have obtained products from Volunteer Distribution and QSP should stop using them and contact the FDA. These products should be retained and securely stored.

To report suspect counterfeit products and other suspect products obtained from Volunteer Distribution or QSP/Montana Health Care Solutions:

Identifying authentic vs. counterfeit packaging

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs